Twice-Weekly Administration of Kisspeptin-54 for 8 Weeks Stimulates Release of Reproductive Hormones in Women With Hypothalamic Amenorrhea
- 27 October 2010
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 88 (6) , 840-847
Abstract
Kisspeptin is a novel therapeutic target for infertility. A single kisspeptin‐54 (KP‐54) injection acutely stimulates the release of reproductive hormones in women with hypothalamic amenorrhea (HA), a commonly occurring condition characterized by absence of menstruation; however, twice‐daily administration of KP‐54 results in tachyphylaxis. We determined the time course of desensitization to twice‐daily KP‐54 injections, compared the effects of twice‐daily and twice‐weekly administration regimens of KP‐54, and studied the effects of long‐term twice‐weekly administration of KP‐54 on the release of reproductive hormones in women with HA. When KP‐54 was administered twice daily, responsiveness to luteinizing hormone (LH) diminished gradually, whereas responsiveness to follicle‐stimulating hormone (FSH) was nearly abolished by day 2. Twice‐weekly KP‐54 administration resulted in only partial desensitization, in contrast to the complete tolerance achieved with twice‐daily administration. Women with HA who were treated with twice‐weekly KP‐54 injections had significantly elevated levels of reproductive hormones after 8 weeks as compared with treatment with saline. No adverse effects were observed. This study provides novel pharmacological data on the effects of KP‐54 on the release of reproductive hormones in women with HA. Clinical Pharmacology & Therapeutics (2010) 88 6, 840–847. doi: 10.1038/clpt.2010.204Keywords
This publication has 31 references indexed in Scilit:
- Kisspeptin-10, a KISS1-Derived Decapeptide, Inhibits Tumor Angiogenesis by Suppressing Sp1-Mediated VEGF Expression and FAK/Rho GTPase ActivationCancer Research, 2009
- KiSS1 suppresses TNFα‐induced breast cancer cell invasion via an inhibition of RhoA‐Mediated NF‐κB activationJournal of Cellular Biochemistry, 2009
- Discovery of Potent Kisspeptin Antagonists Delineate Physiological Mechanisms of Gonadotropin RegulationThe Journal of Neuroscience, 2009
- AGPR54-Activating Mutation in a Patient with Central Precocious PubertyNew England Journal of Medicine, 2008
- Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Central and Peripheral Administration of Kisspeptin‐10 Stimulates the Hypothalamic‐Pituitary‐Gonadal AxisJournal of Neuroendocrinology, 2004
- Kisspeptin Activation of Gonadotropin Releasing Hormone Neurons and Regulation of KiSS-1 mRNA in the Male RatNeuroendocrinology, 2004
- TheGPR54Gene as a Regulator of PubertyNew England Journal of Medicine, 2003
- Nutritional and Endocrine-Metabolic Aberrations in Women with Functional Hypothalamic AmenorrheaThe Journal of Clinical Endocrinology & Metabolism, 1998
- Height and Weight at Menarche and a Hypothesis of Critical Body Weights and Adolescent EventsScience, 1970